tradingkey.logo
tradingkey.logo
Search

Retractable Technologies Inc

RVP
Add to Watchlist
0.729USD
+0.009+1.19%
Close 07/01, 16:00ETQuotes delayed by 15 min
21.81MMarket Cap
LossP/E TTM

More Details of Retractable Technologies Inc Company

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Retractable Technologies Inc Info

Ticker SymbolRVP
Company nameRetractable Technologies Inc
IPO dateMay 04, 2001
CEOShaw (Thomas J)
Number of employees221
Security typeOrdinary Share
Fiscal year-endMay 04
Address511 Lobo Lane
CityLITTLE ELM
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code75068-0009
Phone19722941010
Websitehttps://retractable.com/
Ticker SymbolRVP
IPO dateMay 04, 2001
CEOShaw (Thomas J)

Company Executives of Retractable Technologies Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.66M
+1.99%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.66M
+1.99%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of Retractable Technologies Inc?

The top five shareholders of Retractable Technologies Inc are: Mr. Thomas J. Shaw

How many institutions hold shares of Retractable Technologies Inc (RVP)?

As of 2026Q1, 62 institutions hold shares of Retractable Technologies Inc, with a combined market value of approximately 3.30M, accounting for 11.01% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 627168.00.

What is the biggest source of revenue for Retractable Technologies Inc?

In 2026Q1, the Syringes business generated the highest revenue for Retractable Technologies Inc, amounting to 24.91M and accounting for 65.10% of total revenue.